Search results for " Genes"

showing 10 items of 322 documents

Zvaigžņotā Debess: 2004/05, Ziema

2004

Contents: Ņ.Ozoliņa. Earthquakes in Latvia ; I.Daube. Space Craft “Ranger-7” ; M. Gailis. Moon Investigation in Riga ; J.Tambergs. Problems of Dialogue between Quantum Mechanics and Theology (concluded) ; Z Alksne, A.Alksnis. Ultra-Cool Dwarf Pair Weighed ; A.Balklavs. Successful Hunt of Protostars ; A.Balklavs. Silhouette of a Black Hole ; A.Balklavs. A Distant Giant Quasar ; A.Balklavs. Cosmic Objects in Captivating Photos – 3 ; J.Freimanis. Extragalactic Planetary Nebulae ; J.Jaunbergs. Cassini Enters the Saturnian System ; D.Krieviņš. Space Launchers of Early XXI Century. The Commonwealth of Independent States (CIS) ; J.Bārzdiņš. Professor Rusins-Martins Freivalds on the Path of Science…

Novembra kāvi Baltijas debesīsGalēji auksto punduru sistēma 2MASSW J0746425+2000321Herbiga-Haro objekti HH-30 HH-34 HH-47Krustvārdu mīklaLīgatnes meteorīts – hipotēzeProtozvaigznesPlanetārie miglāji – NGC 2392 (Eskimosa miglājs) NGC 6369 (Spociņa miglājs)Starptautiskā komandu olimpiāde “Baltijas ceļš – 2003” – uzdevumu atrisinājumiRisina lasītājsNASA Genesis – Saules vēja paraugiLU profesors Rūsiņš-Mārtiņš FreivaldsZemestrīces LatvijāBlumbaha spoguļteleskops BSTPirmās galaktikasCassini misija Saturna sistēmāJakobs Juliuss ZeibotsJupitera pavadoņa Jo putekļiRīgas topogrāfiskā uzmērīšanaSavādnieki eksaktajās zinātnēs – Dž.Maksvels O.Sevisaids H.Hercs V.Pauli V.Heizenbergs B.Mandelbrots A.Vītols J.Vītols G.Šipovs A.AkimovsMeteorītu panspermijaPlanetārie miglāji N52 N66 N192 SMP93 Lielajā Magelāna MākonīVenēras un Merkura aizklāšanāsKosmiskie transportlīdzekļi – NVSAstronomiskās parādības - 2005Melnais caurums – siluetsKalenaisa – “Hebridu Stounhendža”Planētu redzamības kompleksā diagramma 2005Zvaigžņu lietus novembrīESA Smart-1Astronomiskās parādības - 2004Kvantu mehānika un teoloģijaMilzu kvazārs J1432+158Londonas universitātes Berkbeka koledža
researchProduct

Better the devil you know? Guidelines for insightful utilization of nrDNA ITS in species-level evolutionary studies in plants.

2006

The internal transcribed spacers (ITS) of the nuclear ribosomal 18S–5.8S–26S cistron continue to be the most popular non-plastid region for species-level phylogenetic studies of plant groups despite the early warnings about their potential Xaws, which may ultimately result in incorrect assumptions of orthology. It has been gradually realized that the alternative target regions in the nuclear genome (lowcopy nuclear genes, LCNG) are burdened with similar problems. The consequence is that, to date, developing useful LCNG for nonmodel organisms requires an investment in time and eVort that hinders its use as a real practical alternative for many labs. It is here argued that ITS sequences, desp…

Nuclear geneTranscription GeneticPseudogeneLineage (evolution)Low-copy nuclear genesBiologyDNA RibosomalCistronPhylogeneticsOrthologyGeneticsAnimalsCladeMolecular BiologyEcology Evolution Behavior and SystematicsOrganismPlant phylogenyOligonucleotide Array Sequence AnalysisGeneticsCell NucleusPlantsBiological EvolutionnrDNA ITSEvolutionary biologyHorizontal gene transferMolecular phylogenetics and evolution
researchProduct

Apulian olive sapwood endophytes to cope with Xylella fastidiosa: community analysis, antagonists screening, colonization efficiency, and genes expre…

2021

This dissertation comprises a series of studies aimed at exploring the cultivable endophytic communities indigenous to the sapwood of Apulian olive cultivars, identifying potential antagonists against Xylella fastidiosa, pauca ST53, and demonstrating their colonization efficiency and associated effects on olive defence-related genes. This work starts with an extensive analysis of cultivable sapwood endophytes from resistant and susceptible cultivars distributed across phytosanitary zones in Apulia. After multiple isolation of endophyte colonies, the results were translated into quantitative indicators. It was found that the resistant cultivar 'Leccino' showed high stability and diversity of…

Olive Endophytes Diversity Xylella fastidiosa Antagonists Colonization Genes expressionSettore AGR/12 - Patologia Vegetale
researchProduct

Insight into genetic susceptibility to male breast cancer by multigene panel testing: results from a multicenter study in Italy

2019

Breast cancer (BC) in men is rare and genetic predisposition is likely to play a relevant role in its etiology. Inherited mutations in BRCA1/2 account for about 13% of all cases and additional genes that may contribute to the missing heritability need to be investigated. In our study, a well-characterized series of 523 male BC (MBC) patients from the Italian multicenter study on MBC, enriched for non-BRCA1/2 MBC cases, was screened by a multigene custom panel of 50 cancer-associated genes. The main clinical-pathologic characteristics of MBC in pathogenic variant carriers and non-carriers were also compared. BRCA1/2 pathogenic variants were detected in twenty patients, thus, a total of 503 n…

OncologyAdultMaleCancer Researchmedicine.medical_specialtyPALB2Adenomatous Polyposis Coli Proteinmale breast cancerGene mutationBreast Neoplasms MaleDNA GlycosylasesBRCA1/2; cancer susceptibility genes; germline mutations; male breast cancer; multigene panel testing03 medical and health sciencesYoung Adult0302 clinical medicinemultigene panel testingMUTYHMissing heritability problemBRCA1/2Internal medicinemedicineGenetic predispositionHumansGenetic Predisposition to Diseasecancer susceptibility genecancer susceptibility genesskin and connective tissue diseasesCHEK2Genetic Association StudiesAgedAged 80 and overbusiness.industryCase-control studySequence Analysis DNAMiddle Agedmedicine.diseaseCheckpoint Kinase 2germline mutationOncologyItaly030220 oncology & carcinogenesisMale breast cancerCase-Control StudiesMutationgermline mutationsbusinessFanconi Anemia Complementation Group N Protein
researchProduct

How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes?

2012

The need to answer the question “how much of the familial risk is currently explained by the known genes?” has increased ,and although BRCA1 and BRCA2 are considered the two major breast cancer (BC) susceptibility genes, they do not justify the entire percentage of all hereditary BC cases. The current consensus is that other BC predisposing genes could explain at least a portion of the remaining non-mutated familial cases, including not only other high- penetrance BC genes, but also moderate and low-penetrance genes. Considering these three different categories of genes, a gap of risk estimation in breast cancer can be observed. Moreover, different researchers tried to give significance to …

OncologyBreast cancer high-penetrance genes low-moderate penetrance genes.medicine.medical_specialtybusiness.industryInternal medicineObstetrics and GynecologyMedicineFamilial breast cancerbusinessGeneCurrent Women's Health Reviews
researchProduct

79 VUS VARIANTS IN BRCA GENES OF HEREDITARY BREAST/OVARIAN CANCER

2010

OncologyBreast ovarian cancermedicine.medical_specialtyOncologybusiness.industryInternal medicinemedicineRadiology Nuclear Medicine and imagingGeneral MedicinebusinessBrca genesCancer Treatment Reviews
researchProduct

Targeting breast cancer initiating cells: advances in breast cancer research and therapy

2014

Over the past 10 years there have been significant advances in our understanding of breast cancer and the important roles that breast cancer initiating cells (CICs) play in the development and resistance of breast cancer. Breast CICs endowed with self-renewing and tumor-initiating capacities are believed to be responsible for the relapses which often occur after various breast cancer therapies. In this review, we will summarize some of the key developments in breast CICs which will include discussion of some of the key genes implicated: estrogen receptor (. ER), HER2, BRCA1, TP53, PIK3CA, RB, P16INK1 and various miRs as well some drugs which are showing promise in targeting CICs. In additio…

OncologyCancer Researchmedicine.medical_specialtyKey genesmedicine.medical_treatmentEstrogen receptorAntineoplastic AgentsBreast NeoplasmsMiRCancer stem cells; ER; HER2; Hormonal therapy; MiRs; Targeted therapy; Therapy resistanceTargeted therapyMiRsTargeted therapyBreast cancerCancer stem cellInternal medicineHER2GeneticsmedicineHumansTreatment resistanceskin and connective tissue diseasesMolecular Biologybusiness.industryCancer stem cellsTherapy resistanceProteinsmedicine.diseaseClinical researchERNeoplastic Stem CellsMolecular MedicineHormonal therapyFemalebusinessHormonal therapyCancer stem cells HER2 ER miRs Targeted therapy Hormonal therapy Therapy resistance
researchProduct

Genetic determinants of ototoxicity during and after childhood cancer treatment: Protocol for the pancarelife study

2019

BACKGROUND: Survival rates after childhood cancer now reach nearly 80% in developed countries. However, treatments that lead to survival and cure can cause serious adverse effects with lifelong negative impacts on survivor quality of life. Hearing impairment is a common adverse effect in children treated with cisplatin-based chemotherapy or cranial radiotherapy. Ototoxicity can extend from high-tone hearing impairment to involvement of speech frequencies. Hearing impairment can impede speech and language and neurocognitive development. Although treatment-related risk factors for hearing loss following childhood cancer treatment have been identified, the individual variability in toxicity of…

OncologyCandidate gene020205 medical informaticscisplatinCHILDREN02 engineering and technologyVARIANTSPLATINUM-INDUCED OTOTOXICITYChildhood cancer survivors0302 clinical medicineTPMT0202 electrical engineering electronic engineering information engineeringProtocolGWASgenetics030212 general & internal medicineSURVIVORSGeneral MedicineCHEMOTHERAPY3. Good healthototoxicityCohortmedicine.symptomcandidate genes020 Library & information sciencesmedicine.medical_specialtyINDUCED HEARING-LOSSHearing losschildhood cancer survivors610 Medicine & healthINTERNATIONAL SOCIETYCandidate genes03 medical and health sciencesACYP2OtotoxicitySDG 3 - Good Health and Well-being360 Social problems & social servicesInternal medicinemedicineGenetic predispositionGeneticsCISPLATIN-INDUCED OTOTOXICITYAdverse effecthearing lossbusiness.industryCancerHearing lossmedicine.diseaseOtotoxicityClinical trialCisplatinbusinessPolymorphismspolymorphisms
researchProduct

Effect of genetic variation in CYP450 on Gonadal impairment in a European cohort of female childhood cancer survivors, based on a candidate gene appr…

2021

Background: Female childhood cancer survivors (CCSs) carry a risk of therapy-related gonadal dysfunction. Alkylating agents (AA) are well-established risk factors, yet inter-individual variability in ovarian function is observed. Polymorphisms in CYP450 enzymes may explain this variability in AA-induced ovarian damage. We aimed to evaluate associations between previously identified genetic polymorphisms in CYP450 enzymes and AA-related ovarian function among adult CCSs. Methods: Anti-Müllerian hormone (AMH) levels served as a proxy for ovarian function in a discovery cohort of adult female CCSs, from the pan-European PanCareLIFE cohort (n = 743

OncologyInfertilityCancer ResearchCandidate genemedicine.medical_specialtyendocrine systemendocrine system diseasesMedizinAnti-Müllerian hormoneArticleHealthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]Childhood cancer survivors03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingInterquartile rangeInternal medicineGenetic variationGenetic modelmedicineChemotherapyFertility preservationRC254-282030304 developmental biology0303 health sciencesbiologybusiness.industryNeoplasms. Tumors. Oncology. Including cancer and carcinogensAnti-Müllerian hormonemedicine.diseaseOvarian functionCytochrome P450 genesWomen's cancers Radboud Institute for Health Sciences [Radboudumc 17]3. Good healthOncology030220 oncology & carcinogenesisCohortbiology.proteinCandidate gene approachbusinessGeneral Economics Econometrics and FinanceCancers
researchProduct

Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations

2013

<b><i>Objectives:</i></b> The rapid fatality of pancreatic cancer is, in large part, the result of diagnosis at an advanced stage in the majority of patients. Identification of individuals at risk of developing pancreatic adenocarcinoma would be useful to improve the prognosis of this disease. There is presently no biological or genetic indicator allowing the detection of patients at risk. Our main goal was to identify copy number variants (CNVs) common to all patients with sporadic pancreatic cancer. <b><i>Methods:</i></b> We analyzed gene CNVs in leukocyte DNA from 31 patients with sporadic pancreatic adenocarcinoma and from 93 matched contr…

OncologyMaleCancer Researchmedicine.medical_specialtySettore MED/06 - Oncologia MedicaGene DosageCancer-associated genesBiologyAdenocarcinomaGene dosagePolymorphism Single NucleotideSensitivity and SpecificityGermlineGermline mutationGermline alterationsPolymorphism (computer science)Internal medicinePancreatic cancermedicinepancreatic adenocarcinomaHumansGenetic Predisposition to DiseaseCopy number variationsCopy-number variationGerm-Line MutationGermline alterationAgedCancer-associated geneCopy number variations; Cancer-associated genes; Germline alterations; Sporadic pancreatic cancerCopy number variationCase-control studyGeneral MedicineDNA NeoplasmMiddle Agedmedicine.diseasePancreatic NeoplasmsSporadic pancreatic cancerOncologyTissue Array AnalysisCase-Control StudiesAdenocarcinomaFemale
researchProduct